加拿大公共卫生免疫计划的伦理审查
Ethics check-up of public health immunization programs in Canada.
作者信息
MacDonald Noni E, Harmon Shawn, Graham Janice E
机构信息
Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, NS.
Policy Analyst, Health Law Institute, Schulich School of Law, Dalhousie University, Halifax, NS.
出版信息
Can Commun Dis Rep. 2021 May 7;47(4):224-231. doi: 10.14745/ccdr.v47i04a09.
The World Health Organization (WHO) recognizes immunization as one of the most successful and effective public health interventions for saving lives. In developing a roadmap for prioritizing use of the coronavirus disease 2019 (COVID-19) vaccines in the context of limited supply, WHO highlighted the importance of a values (ethical principles) framework. Immunization does need to be subject to independent ethical scrutiny of vaccine research data, manufacturing practices, the legal and ethical assurance of informed consent, and also social justice issues with respect to program equity, including right to access. An ethics review of Australia's immunization program was reported in 2012. This CANVax (Canadian Vaccination Evidence Resource and Exchange Centre) Brief offers an ethics review of immunization in Canada using the criteria utilized for Australia.
世界卫生组织（WHO）将免疫接种视为拯救生命最成功、最有效的公共卫生干预措施之一。在制定2019冠状病毒病（COVID-19）疫苗在供应有限情况下的优先使用路线图时，WHO强调了价值观（伦理原则）框架的重要性。免疫接种确实需要接受对疫苗研究数据、生产实践、知情同意的法律和伦理保障以及与项目公平性相关的社会正义问题（包括获取权）进行独立的伦理审查。2012年报告了对澳大利亚免疫接种计划的伦理审查。这份加拿大疫苗接种证据资源与交流中心（CANVax）简报采用适用于澳大利亚的标准，对加拿大的免疫接种进行了伦理审查。
Zotero 插件